Lilly Asia Ventures sees perfect timing for China/Western partnering

Lilly Asia Ventures’ Darren Ji has deep experience in international dealmaking, coupled with specific knowledge of what’s needed in the Chinese market, having been a VP at Roche Partnering based in Shanghai. For Lilly Asia Ventures, a fund with an Asian background but a global focus, it’s perfect timing to enter an even more productive phase in cross-border discussions between Chinese and Western companies, particularly in immunotherapies for cancer.

Meet and network with industry leaders like Darren Ji at China Showcase, January 7, and Biotech Showcase, January 8–10, 2018.